{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:16:54Z","timestamp":1787977014294,"version":"build-2784847793"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T00:00:00Z","timestamp":1585008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Aberrant expression of miRNAs in pancreatic islets is closely related to the development of type 1 diabetes (T1D). The aim of this study was to identify key miRNAs dysregulated in pancreatic islets during T1D progression and to develop a theranostic approach to modify their expression using an MRI-based nanodrug consisting of iron oxide nanoparticles conjugated to miRNA-targeting oligonucleotides in a mouse model of T1D. Isolated pancreatic islets were derived from NOD mice of three distinct age groups (3, 8 and 18-week-old). Total RNA collected from cultured islets was purified and global miRNA profiling was performed with 3D-Gene global miRNA microarray mouse chips encompassing all mouse miRNAs available on the Sanger miRBase V16. Of the miRNAs that were found to be differentially expressed across three age groups, we identified one candidate (miR-216a) implicated in beta cell proliferation for subsequent validation by RT-PCR. Alterations in miR-216a expression within pancreatic beta cells were also examined using <jats:italic>in situ<\/jats:italic> hybridization on the frozen pancreatic sections. For <jats:italic>in vitro<\/jats:italic> studies, miR-216a mimics\/inhibitors were conjugated to iron oxide nanoparticles and incubated with beta cell line, \u03b2TC-6. Cell proliferation marker Ki67 was evaluated. Expression of the phosphatase and tensin homolog (PTEN), which is one of the direct targets of miR-216a, was analyzed using western blot. For <jats:italic>in vivo<\/jats:italic> study, the miR-216a mimics\/inhibitors conjugated to the nanoparticles were injected into 12-week-old female diabetic Balb\/c mice via pancreatic duct. The delivery of the nanodrug was monitored by <jats:italic>in vivo<\/jats:italic> MRI. Blood glucose of the treated mice was monitored post injection. <jats:italic>Ex vivo<\/jats:italic> histological analysis of the pancreatic sections included staining for insulin, PTEN and Ki67. miRNA microarray demonstrated that the expression of miR-216a in the islets from NOD mice significantly changed during T1D progression. <jats:italic>In vitro<\/jats:italic> studies showed that treatment with a miR-216a inhibitor nanodrug suppressed proliferation of beta cells and increased the expression of PTEN, a miR-216a target. In contrast, introduction of a mimic nanodrug decreased PTEN expression and increased beta cell proliferation. Animals treated <jats:italic>in vivo<\/jats:italic> with a mimic nanodrug had higher insulin-producing functionality compared to controls. These observations were in line with downregulation of PTEN and increase in beta cell proliferation in that group. Our studies demonstrated that miR-216a could serve as a potential therapeutic target for the treatment of diabetes. miR-216a-targeting theranostic nanodrugs served as exploratory tools to define functionality of this miRNA in conjunction with <jats:italic>in vivo<\/jats:italic> MR imaging.<\/jats:p>","DOI":"10.1038\/s41598-020-62269-4","type":"journal-article","created":{"date-parts":[[2020,3,24]],"date-time":"2020-03-24T11:06:27Z","timestamp":1585047987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["miR-216a-targeting theranostic nanoparticles promote proliferation of insulin-secreting cells in type 1 diabetes animal model"],"prefix":"10.1038","volume":"10","author":[{"given":"Ping","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack Owen","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Karl","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,24]]},"reference":[{"issue":"10","key":"62269_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1038\/nbt1006-1211","volume":"24","author":"V Wagner","year":"2006","unstructured":"Wagner, V., Dullaart, A., Bock, A. K. & Zweck, A. The emerging nanomedicine landscape. Nat. Biotechnol. 24(10), 1211\u20137 (2006).","journal-title":"Nat. Biotechnol."},{"issue":"22","key":"62269_CR2","doi-asserted-by":"publisher","first-page":"6322","DOI":"10.7150\/thno.27828","volume":"8","author":"S Ray","year":"2018","unstructured":"Ray, S. et al. Dendrimer- and copolymer-based nanoparticles for magnetic resonance cancer theranostics. Theranostics. 8(22), 6322\u201349. (2018).","journal-title":"Theranostics."},{"issue":"1","key":"62269_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.7150\/thno.29431","volume":"9","author":"S Gao","year":"2019","unstructured":"Gao, S. et al. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy. Theranostics. 9(1), 126\u201351. (2019).","journal-title":"Theranostics."},{"key":"62269_CR4","doi-asserted-by":"crossref","unstructured":"Panwar, N., et al. Nanocarbons for Biology and Medicine: Sensing, Imaging, and Drug Delivery. Chem Rev. (2019).","DOI":"10.1021\/acs.chemrev.9b00099"},{"issue":"19","key":"62269_CR5","doi-asserted-by":"publisher","first-page":"10907","DOI":"10.1021\/cr500314d","volume":"115","author":"S Kunjachan","year":"2015","unstructured":"Kunjachan, S., Ehling, J., Storm, G., Kiessling, F. & Lammers, T. Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. Chem. Rev. 115(19), 10907\u201337 (2015).","journal-title":"Chem. Rev."},{"issue":"2","key":"62269_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.2337\/db10-1400","volume":"60","author":"P Wang","year":"2011","unstructured":"Wang, P. et al. Combined small interfering RNA therapy and in vivo magnetic resonance imaging in islet transplantation. Diabetes. 60(2), 565\u201371 (2011).","journal-title":"Diabetes."},{"issue":"6","key":"62269_CR7","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.7150\/thno.32362","volume":"9","author":"C Moore","year":"2019","unstructured":"Moore, C. & Jokerst, J. V. Strategies for Image-Guided Therapy, Surgery, and Drug Delivery Using Photoacoustic Imaging. Theranostics. 9(6), 1550\u201371 (2019).","journal-title":"Theranostics."},{"issue":"5","key":"62269_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11307-018-1255-2","volume":"20","author":"F Man","year":"2018","unstructured":"Man, F., Lammers, T. & TMdR, R. Imaging Nanomedicine-Based Drug Delivery: a Review of Clinical Studies. Mol. Imaging Biol. 20(5), 683\u201395 (2018).","journal-title":"Mol. Imaging Biol."},{"issue":"1","key":"62269_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","volume":"52","author":"AE Butler","year":"2003","unstructured":"Butler, A. E. et al. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes. 52(1), 102\u201310 (2003).","journal-title":"Diabetes."},{"issue":"4","key":"62269_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/nrd4231","volume":"13","author":"A Vetere","year":"2014","unstructured":"Vetere, A., Choudhary, A., Burns, S. M. & Wagner, B. K. Targeting the pancreatic beta-cell to treat diabetes. Nat. Rev. Drug. Discov. 13(4), 278\u201389 (2014).","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"7308","key":"62269_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/nature09267","volume":"466","author":"H Guo","year":"2010","unstructured":"Guo, H., Ingolia, N. T., Weissman, J. S. & Bartel, D. P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 466(7308), 835\u201340 (2010).","journal-title":"Nature."},{"issue":"12","key":"62269_CR12","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1210\/me.2014-1306","volume":"28","author":"S Ozcan","year":"2014","unstructured":"Ozcan, S. Minireview: microRNA function in pancreatic beta cells. Mol. Endocrinol. 28(12), 1922\u201333 (2014).","journal-title":"Mol. Endocrinol."},{"key":"62269_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9084","volume":"6","author":"C Jacovetti","year":"2015","unstructured":"Jacovetti, C., Matkovich, S. J., Rodriguez-Trejo, A., Guay, C. & Regazzi, R. Postnatal beta-cell maturation is associated with islet-specific microRNA changes induced by nutrient shifts at weaning. Nat. Commun. 6, 8084 (2015).","journal-title":"Nat. Commun."},{"issue":"Suppl 3","key":"62269_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/j.1463-1326.2012.01654.x","volume":"14","author":"C Guay","year":"2012","unstructured":"Guay, C. et al. Emerging roles of non-coding RNAs in pancreatic beta-cell function and dysfunction. Diabetes Obes. Metab. 14(Suppl 3), 12\u201321 (2012).","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"62269_CR15","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.2337\/db11-1086","volume":"61","author":"E Roggli","year":"2012","unstructured":"Roggli, E. et al. Changes in microRNA expression contribute to pancreatic beta-cell dysfunction in prediabetic NOD mice. Diabetes. 61(7), 1742\u201351 (2012).","journal-title":"Diabetes."},{"key":"62269_CR16","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","volume":"23","author":"MS Anderson","year":"2005","unstructured":"Anderson, M. S. & Bluestone, J. A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23, 447\u201385 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"62269_CR17","doi-asserted-by":"crossref","unstructured":"Zmuda, E. J., Powell, C. A., Hai, T. A method for murine islet isolation and subcapsular kidney transplantation. J Vis Exp. (50) (2011).","DOI":"10.3791\/2096"},{"issue":"5","key":"62269_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2337\/diab.46.5.765","volume":"46","author":"M Vigneau-Hermellin","year":"1997","unstructured":"Vigneau-Hermellin, M. et al. Rejection of islets differing by a single antigen is dependent on donor MHC. Diabetes. 46(5), 765\u20139 (1997).","journal-title":"Diabetes."},{"issue":"5","key":"62269_CR19","doi-asserted-by":"publisher","first-page":"e5540","DOI":"10.1371\/journal.pone.0005540","volume":"4","author":"F Sato","year":"2009","unstructured":"Sato, F., Tsuchiya, S., Terasawa, K. & Tsujimoto, G. Intra-platform repeatability and inter-platform comparability of microRNA microarray technology. PLoS One. 4(5), e5540 (2009).","journal-title":"PLoS One."},{"issue":"1","key":"62269_CR20","doi-asserted-by":"publisher","first-page":"e16435","DOI":"10.1371\/journal.pone.0016435","volume":"6","author":"F Sato","year":"2011","unstructured":"Sato, F. et al. MicroRNA profile predicts recurrence after resection in patients with hepatocellular carcinoma within the Milan Criteria. PLoS One. 6(1), e16435 (2011).","journal-title":"PLoS One."},{"issue":"3","key":"62269_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/gcc.20837","volume":"50","author":"M Hisaoka","year":"2011","unstructured":"Hisaoka, M. et al. Identification of altered MicroRNA expression patterns in synovial sarcoma. Genes. Chromosomes Cancer. 50(3), 137\u201345 (2011).","journal-title":"Genes. Chromosomes Cancer."},{"issue":"2","key":"62269_CR22","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/bioinformatics\/19.2.185","volume":"19","author":"BM Bolstad","year":"2003","unstructured":"Bolstad, B. M., Irizarry, R. A., Astrand, M. & Speed, T. P. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics. 19(2), 185\u201393 (2003).","journal-title":"Bioinformatics."},{"issue":"1","key":"62269_CR23","doi-asserted-by":"publisher","first-page":"e30415","DOI":"10.1371\/journal.pone.0030415","volume":"7","author":"S Negi","year":"2012","unstructured":"Negi, S. et al. Analysis of beta-cell gene expression reveals inflammatory signaling and evidence of dedifferentiation following human islet isolation and culture. PLoS One. 7(1), e30415 (2012).","journal-title":"PLoS One."},{"issue":"4","key":"62269_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2002-3-4-research0019","volume":"3","author":"J Landgrebe","year":"2002","unstructured":"Landgrebe, J., Wurst, W. & Welzl, G. Permutation-validated principal components analysis of microarray data. Genome Biol. 3(4), RESEARCH0019 (2002).","journal-title":"Genome Biol."},{"issue":"6","key":"62269_CR25","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.2337\/db11-0952","volume":"61","author":"S Greco","year":"2012","unstructured":"Greco, S. et al. MicroRNA dysregulation in diabetic ischemic heart failure patients. Diabetes. 61(6), 1633\u201341 (2012).","journal-title":"Diabetes."},{"issue":"1","key":"62269_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jim.2005.07.006","volume":"305","author":"JM Luk","year":"2005","unstructured":"Luk, J. M., Wang, P. P., Lee, C. K., Wang, J. H. & Fan, S. T. Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J. Immunol. Methods. 305(1), 39\u201347 (2005).","journal-title":"J. Immunol. Methods."},{"issue":"7","key":"62269_CR27","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1210\/en.2014-1966","volume":"156","author":"X Jiang","year":"2015","unstructured":"Jiang, X. et al. miR-144\/451 Promote Cell Proliferation via Targeting PTEN\/AKT Pathway in Insulinomas. Endocrinology. 156(7), 2429\u201339 (2015).","journal-title":"Endocrinology."},{"key":"62269_CR28","doi-asserted-by":"crossref","unstructured":"Wang, P., et al. Magnetic resonance imaging of intra-pancreatic ductal nanoparticle delivery to islet cells. Diabetes Metab Res Rev. (2016).","DOI":"10.1002\/dmrr.2881"},{"issue":"5","key":"62269_CR29","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.2337\/db13-1543","volume":"63","author":"P Wang","year":"2014","unstructured":"Wang, P. et al. GLP-1R-targeting magnetic nanoparticles for pancreatic islet imaging. Diabetes. 63(5), 1465\u201374 (2014).","journal-title":"Diabetes."},{"issue":"5","key":"62269_CR30","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1158\/0008-5472.CAN-03-3230","volume":"64","author":"A Moore","year":"2004","unstructured":"Moore, A., Medarova, Z., Potthast, A. & Dai, G. In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res. 64(5), 1821\u20137 (2004).","journal-title":"Cancer Res."},{"key":"62269_CR31","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1166\/jbn.2014.1795","volume":"10","author":"BY Yoo","year":"2014","unstructured":"Yoo, B. Y. et al. Design of nanodrugs for miRNA targeting in tumor cells. J. Biomed. Nanotechnology. 10, 1114\u201322 (2014).","journal-title":"J. Biomed. Nanotechnology."},{"issue":"20","key":"62269_CR32","doi-asserted-by":"publisher","first-page":"4407","DOI":"10.1158\/0008-5472.CAN-15-0888","volume":"75","author":"B Yoo","year":"2015","unstructured":"Yoo, B. et al. Combining miR-10b-Targeted Nanotherapy with Low-Dose Doxorubicin Elicits Durable Regressions of Metastatic Breast Cancer. Cancer research. 75(20), 4407\u201315 (2015).","journal-title":"Cancer research."},{"key":"62269_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/srep45060","volume":"7","author":"B Yoo","year":"2017","unstructured":"Yoo, B. et al. Therapy targeted to the metastatic niche is effective in a model of stage IV breast cancer. Sci. Rep. 7, 45060 (2017).","journal-title":"Sci. Rep."},{"issue":"12","key":"62269_CR34","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.2337\/db12-0441","volume":"61","author":"P Wang","year":"2012","unstructured":"Wang, P. et al. A theranostic small interfering RNA nanoprobe protects pancreatic islet grafts from adoptively transferred immune rejection. Diabetes. 61(12), 3247\u201354 (2012).","journal-title":"Diabetes."},{"issue":"3","key":"62269_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ar.22641","volume":"296","author":"EC Jensen","year":"2013","unstructured":"Jensen, E. C. Quantitative analysis of histological staining and fluorescence using Image. J. Anat. Rec. 296(3), 378\u201381 (2013).","journal-title":"J. Anat. Rec."},{"issue":"3","key":"62269_CR36","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1258\/la.2010.010090","volume":"45","author":"MC Deeds","year":"2011","unstructured":"Deeds, M. C. et al. Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models. Lab. Anim. 45(3), 131\u201340 (2011).","journal-title":"Lab. Anim."},{"issue":"7","key":"62269_CR37","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/ncb1897","volume":"11","author":"M Kato","year":"2009","unstructured":"Kato, M. et al. TGF-beta activates Akt kinase through a microRNA-dependent amplifying circuit targeting PTEN. Nat. Cell Biol. 11(7), 881\u20139 (2009).","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"62269_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/hep.26369","volume":"58","author":"H Xia","year":"2013","unstructured":"Xia, H., Ooi, L. L. & Hui, K. M. MicroRNA-216a\/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer. Hepatology. 58(2), 629\u201341 (2013).","journal-title":"Hepatology."},{"key":"62269_CR39","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.2147\/OTT.S114318","volume":"10","author":"H Liu","year":"2017","unstructured":"Liu, H., Pan, Y., Han, X., Liu, J. & Li, R. MicroRNA-216a promotes the metastasis and epithelial-mesenchymal transition of ovarian cancer by suppressing the PTEN\/AKT pathway. Onco Targets Ther. 10, 2701\u20139 (2017).","journal-title":"Onco Targets Ther."},{"issue":"12","key":"62269_CR40","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1038\/gt.2011.50","volume":"18","author":"JA Broderick","year":"2011","unstructured":"Broderick, J. A. & Zamore, P. D. MicroRNA therapeutics. Gene Ther. 18(12), 1104\u201310 (2011).","journal-title":"Gene Ther."},{"key":"62269_CR41","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.phrs.2013.06.005","volume":"75","author":"Y Mao","year":"2013","unstructured":"Mao, Y., Mohan, R., Zhang, S. & Tang, X. MicroRNAs as pharmacological targets in diabetes. Pharmacol. Res. 75, 37\u201347 (2013).","journal-title":"Pharmacol. Res."},{"issue":"51","key":"62269_CR42","doi-asserted-by":"publisher","first-page":"88870","DOI":"10.18632\/oncotarget.21488","volume":"8","author":"Y Tao","year":"2017","unstructured":"Tao, Y. et al. MicroRNA-216a inhibits the metastasis of gastric cancer cells by targeting JAK2\/STAT3-mediated EMT process. Oncotarget. 8(51), 88870\u201381 (2017).","journal-title":"Oncotarget."},{"issue":"8","key":"62269_CR43","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.3727\/096504017X14874323871217","volume":"25","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Overexpression of MicroRNA-216a Suppresses Proliferation, Migration, and Invasion of Glioma Cells by Targeting Leucine-Rich Repeat-Containing G Protein-Coupled Receptor 5. Oncol. Res. 25(8), 1317\u201327 (2017).","journal-title":"Oncol. Res."},{"issue":"5","key":"62269_CR44","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1111\/jcmm.13567","volume":"22","author":"S Yang","year":"2018","unstructured":"Yang, S. et al. MicroRNA-216a induces endothelial senescence and inflammation via Smad3\/IkappaBalpha pathway. J. Cell Mol. Med. 22(5), 2739\u201349 (2018).","journal-title":"J. Cell Mol. Med."},{"issue":"12","key":"62269_CR45","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1128\/MCB.00238-06","volume":"26","author":"KT Nguyen","year":"2006","unstructured":"Nguyen, K. T. et al. Essential role of Pten in body size determination and pancreatic beta-cell homeostasis in vivo. Mol. Cell Biol. 26(12), 4511\u20138 (2006).","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"62269_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ydbio.2009.12.009","volume":"339","author":"S Wang","year":"2010","unstructured":"Wang, S. et al. Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas. Dev. Biol. 339(1), 26\u201337 (2010).","journal-title":"Dev. Biol."},{"issue":"6","key":"62269_CR47","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/acel.12132","volume":"12","author":"N Zeng","year":"2013","unstructured":"Zeng, N. et al. PTEN controls beta-cell regeneration in aged mice by regulating cell cycle inhibitor p16ink4a. Aging Cell. 12(6), 1000\u201311 (2013).","journal-title":"Aging Cell."},{"issue":"2","key":"62269_CR48","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00125-013-3085-8","volume":"57","author":"KT Yang","year":"2014","unstructured":"Yang, K. T. et al. Adult-onset deletion of Pten increases islet mass and beta cell proliferation in mice. Diabetologia. 57(2), 352\u201361 (2014).","journal-title":"Diabetologia."},{"issue":"6","key":"62269_CR49","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1128\/MCB.25.6.2498-2510.2005","volume":"25","author":"C Kurlawalla-Martinez","year":"2005","unstructured":"Kurlawalla-Martinez, C. et al. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol. Cell Biol. 25(6), 2498\u2013510 (2005).","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"62269_CR50","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1074\/jbc.M805183200","volume":"284","author":"A Radziszewska","year":"2009","unstructured":"Radziszewska, A. et al. PTEN deletion and concomitant c-Myc activation do not lead to tumor formation in pancreatic beta cells. J. Biol. Chem. 284(5), 2917\u201322 (2009).","journal-title":"J. Biol. Chem."},{"issue":"1","key":"62269_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gtc.2015.10.009","volume":"45","author":"BP Riff","year":"2016","unstructured":"Riff, B. P. & Chandrasekhara, V. The Role of Endoscopic Retrograde Cholangiopancreatography in Management of Pancreatic Diseases. Gastroenterol. Clin. North. Am. 45(1), 45\u201365 (2016).","journal-title":"Gastroenterol. Clin. North. Am."},{"issue":"11","key":"62269_CR52","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/nbt1117-995","volume":"35","author":"C Sheridan","year":"2017","unstructured":"Sheridan, C. With Alnylam\u2019s amyloidosis success, RNAi approval hopes soar. Nat. Biotechnol. 35(11), 995\u20137 (2017).","journal-title":"Nat. Biotechnol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62269-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62269-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62269-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:41:00Z","timestamp":1670316060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-62269-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["62269"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-62269-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,24]]},"assertion":[{"value":"11 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5302"}}